Litzman calls to put drug for rare genetic disease in basket
In the US, the cost of a single dose of the drug, approved by the US Food and Drug Administration in December, is $125,000.
Health Minister Ya'acov Litzman at the Knesset plenum discussing goverment allowances for the disabled, September 18, 2017.(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)
